Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI In Brief: New Board Member, Funding Opportunities

Executive Summary

The Patient-Centered Outcomes Research Institute welcomes UCSF professor Alicia Fernandez to the board, announces pragmatic trials funding opportunity; Senate bids farewell to PCORI champion Max Baucus.

You may also be interested in...



Sen. Baucus, Key Architect Of Device Tax, Health Reform, To Retire In 2014

Sen. Max Baucus, D-Mont., chairman of the powerful Senate Finance Committee, and one of the key architects of the Affordable Care Act and device tax, says he will serve out his term, but not seek re-election in November 2014.

Driving Rx Adherence In Value-Based Insurance Design Needs More Than Lower Copays – Harvard Researcher

Value-based insurance design offers the promise of offering better quality care and helping to reduce costs, but getting there will require more than trying to influence behavior by reducing copayments, Harvard’s Choudhry said in a recent webinar.

Senate Considers Revised Comparative Effectiveness Plan In Reform Bill

Comparative effectiveness research led by a non-government institute with funding from public and private sources, as envisioned by Sen. Max Baucus, D-Mont., is among the provisions for health care reform that are being debated by the Senate, but some changes to CER provisions were made as the bill moved from the Finance Committee to its current iteration on the Senate floor

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS055924

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel